Though probably too late for this summer, Americans will get more options to ward off skin cancer if the U.S. Senate passes legislation similar to what the U.S. House of Representatives approved by a voice vote this week.
The full House approved the Sunscreen Innovation Act, but a nearly identical bill remains mired in the U.S. Senate’s Committee on Health, Education, Labor, and Pensions, where it has been since it was introduced in March.
The bill calls for the U.S. Food and Drug Administration to streamline regulations that have kept U.S. sunscreens from being made with as many active ingredients as those found in other parts of the world.
U.S. sunscreen manufacturers are limited to three active ingredients domestically, but can sell products in Europe with as many as seven.
To read the full article, click the link below.
